AbbVie presents new therapy that revolutionizes the concept of time per patient

2023-12-19 19:48:52

A real evolution of the concept of time for leukemia patients has begun thanks to a new therapeutic paradigm and a renewed evaluation of the quality of life: this is the objective of AbbVie, which promoted the national congress “Chronic Lymphatic Leukemia : time to live”, in which clinicians and experts gathered in Rome to take stock of the new perspectives of patients.